| Cell-Free, Dendritic Cell-Mimicking Vaccines for Cancer, COVID-19, and Beyond MN Thone, JY Chung, YJ Kwon 2022 AIChE Annual Meeting, 2022 | | 2022 |
| Cell‐Free, Dendritic Cell‐Mimicking Extracellular Blebs for Molecularly Controlled Vaccination MN Thone, JY Chung, D Ingato, ML Lugin, YJ Kwon Advanced therapeutics 6 (1), 2200125, 2023 | 2 | 2023 |
| Chemically and photochemically initiated cell membrane blebbing to induce cell vesicle production, modifications thereof, and uses thereof YJ Kwon, M Thone, M Lugin, DA Ingato US Patent App. 17/268,952, 2021 | | 2021 |
| COVID-19 vaccines: The status and perspectives in delivery points of view JY Chung, MN Thone, YJ Kwon Advanced drug delivery reviews 170, 1-25, 2021 | 455 | 2021 |
| Engineered Extracellular Blebs for Molecular Therapy MN Thone UC Irvine, 2020 | | 2020 |
| Extracellular blebs: Artificially-induced extracellular vesicles for facile production and clinical translation MN Thone, YJ Kwon Methods 177, 135-145, 2020 | 34 | 2020 |
| Facile, Scalable Dendritic Cell-Derived Extracellular Blebs for a Cancer Vaccine M Thone, D Ingato, A Dixit, YJ Kwon 2019 AIChE Annual Meeting, 2019 | | 2019 |
| Natural killer cell induced cellular vesicles for cancer therapy YJ Kwon, M Thone, DA Ingato US Patent App. 17/433,573, 2022 | | 2022 |
| Vaccination against SARS-CoV-2 using extracellular blebs derived from spike protein-expressing dendritic cells JY Chung, MN Thone, JE Davies, JS Gach, DH Davies, DN Forthal, ... Cellular Immunology 386, 104691, 2023 | 5 | 2023 |
